Prosecution Insights
Last updated: July 05, 2026
Application No. 18/054,784

METHODS AND SYSTEMS FOR DISPOSABLE ENDOSCOPE

Final Rejection §112
Filed
Nov 11, 2022
Priority
May 29, 2020 — provisional 63/032,140 +2 more
Examiner
GHIMIRE, SHANKAR RAJ
Art Unit
3795
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Noah Medical Corporation
OA Round
4 (Final)
76%
Grant Probability
Favorable
5-6
OA Rounds
0m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 76% — above average
76%
Career Allowance Rate
215 granted / 282 resolved
+6.2% vs TC avg
Strong +19% interview lift
Without
With
+19.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
44 currently pending
Career history
327
Total Applications
across all art units

Statute-Specific Performance

§103
80.9%
+40.9% vs TC avg
§102
9.3%
-30.7% vs TC avg
§112
6.2%
-33.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 282 resolved cases

Office Action

§112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment Claims 1-2, 4-7, 9-13, 15-22, are rejected. Claims 3, 8, 14, are cancelled. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-2, 4-7, 9-13, 15-22, are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites “when the second bending axis is not aligned with the first bending axis, the second bending axis being oriented in a different spatial direction from the first bending axis such that an additional degree of the articulation movement in a bending direction not accessible by movement about the first bending axis alone is provided.” Based on the recited claim language, it is unclear which element of the endoscopic device the above feature is associated with or providing the above feature. Appropriate correction is required. Claims 1-2, 4-7, 9-13, 15-22 are rejected for being dependent on a rejected base claim. Allowable Subject Matter Claim 1 The following is an examiner’s statement of reasons for allowable subject matter: The prior art of record fails to explicitly teach or fairly suggest, alone or in combination, an endoscopic device: wherein the first external guiding element comprises an articulation control mechanism and is individually controlled to bend the elongate member about a second bending axis, and wherein the second bending axis relative to the first bending axis is configurable such that when the second bending axis is aligned with the first bending axis, an extent of movement about the first bending axis is increased, and when the second bending axis is not aligned with the first bending axis, the second bending axis being oriented in a different spatial direction from the first bending axis, an additional degree of the articulation movement in a bending direction not accessible by movement about the first bending axis alone is provided, along with the remaining features of claim 1. The closest art Walen (US 20210068647) teaches external guiding element, for providing additional degrees of freedom. However, Walen does not teach providing an additional degree of the articulation movement in a bending direction not accessible by the movement about the first bending axis alone. Another art Alvarez (US 20100280449) teaches outer tube (302), and inner tube (312). However, these tubes are controlled by common wire which could not provide additional degree of the articulation movement in a bending direction not accessible by the movement about the first bending axis alone. Accordingly, claim 1 is considered to include allowable subject matter. Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SHANKAR R GHIMIRE whose telephone number is (571)272-0515. The examiner can normally be reached 8 AM - 5 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anhtuan Nguyen can be reached at 571-272-4963. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SHANKAR RAJ GHIMIRE/Examiner, Art Unit 3795 /ANHTUAN T NGUYEN/Supervisory Patent Examiner, Art Unit 3795 06/16/26
Read full office action

Prosecution Timeline

Show 1 earlier event
Feb 11, 2025
Non-Final Rejection mailed — §112
Jul 18, 2025
Response Filed
Aug 14, 2025
Final Rejection mailed — §112
Jan 06, 2026
Request for Continued Examination
Feb 17, 2026
Response after Non-Final Action
Mar 03, 2026
Non-Final Rejection mailed — §112
May 27, 2026
Response Filed
Jun 22, 2026
Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12667239
Endoscopic Vessel Harvesting With Thermal Management and Augmented Reality Display
2y 3m to grant Granted Jun 30, 2026
Patent 12660984
SURGICAL METHODS USING MULTI-SOURCE IMAGING
4y 8m to grant Granted Jun 23, 2026
Patent 12653379
Endoscopic System With Attached Instruments
2y 6m to grant Granted Jun 16, 2026
Patent 12635862
ENDOSCOPE WITH OPTICAL FILTER ARRANGEMENT AND USE
2y 1m to grant Granted May 26, 2026
Patent 12629013
ARTHROSCOPIC PROBE DEVICE, SYSTEM AND METHOD
3y 2m to grant Granted May 19, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
76%
Grant Probability
95%
With Interview (+19.1%)
3y 1m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 282 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month